Clinical Skin Acquires Glytone

Clinical Skin has acquired the dermatological skincare brand Glytone from Pierre Fabre Laboratories.

For over two decades, Glytone has leveraged the expertise of Pierre Fabre Laboratories in dermo-cosmetic solutions, earning a reputation for its effective in-office peel systems and at-home products. A market pioneer in the use of active acids, each Glytone formula features active acids to target and treat several skin concerns, including photo-aging, hyperpigmentation, uneven texture, and acne.

“We are proud of the legacy we have built at Glytone over the past two decades and are confident that joining Clinical Skin’s portfolio will allow the brand to reach new heights.” said Lisa Morris, CEO Pierre Fabre USA.

Clinical Skin provides premium skincare products that blend scientific innovation with advanced skincare expertise. Committed to science, innovation, and luxury, Clinical Skin offers a diverse range of skincare solutions tailored to treat various dermatological concerns. This strategic acquisition underscores Clinical Skin’s dedication to enhancing its premier product range and expanding its influence in the cosmeceutical skincare industry.

“We are extremely excited to welcome Glytone into the Clinical Skin family,” said Jaime Castle, CEO at Clinical Skin. “This acquisition aligns perfectly with our mission to continue to scale our offering of skincare solutions that are firmly backed by science and innovation. Glytone’s commitment to quality and efficacy complements our own values, and we are excited to work together to further elevate our product offerings.”

The financial terms of the deal have not been disclosed.